Trans-caryophyllene inhibits amyloid β (Aβ) oligomer-induced neuroinflammation in BV-2 microglial cells

- TC inhibits the expression of TNF-α, IL-6, and IL-1β induced by Aβ1-42 in BV2 cells.
- TC suppresses the expression of NO, PGE2, iNOS and COX-2 in BV2 cells.
- TC inhibits the expression of TLR4 induced by Aβ1-42 in BV2 cells.
- TC suppresses phosphorylation and degradation of IκBα, nuclear translocation of p65.
- TC suppresses the activation of NF-κB transcriptional activity.

Amyloid β (Aβ) is the major component of senile plaques (SP) in the brains of Alzheimer's disease (AD) patients, and serves as an inflammatory stimulus for microglia. Trans-caryophyllene (TC), a major component in the essential oils derived from various species of medicinal plants, has displayed its neuro-protective effects in previous studies. However, whether TC has a protective role in AD remains unknown. In this study, the effects of TC on Aβ1-42-induced neuro-inflammation were investigated. We found that TC reduced the release of LDH in BV-2 microglial cells treated with Aβ1-42. In addition, pretreatment of BV2 microglia with TC at concentrations of 10, 25, and 50 μM prior to Aβ stimulation led to significant inhibition of nitric oxide (NO) and prostaglandin E2 (PGE2) production, expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), and secretion of pro-inflammatory cytokines. Notably, our results indicate that TC remarkably attenuated Aβ1-42-activated overexpression of toll-like receptor 4 (TLR4). We further demonstrated that TC markedly reversed Aβ1-42-induced phosphorylation and degradation of IκBα, nuclear translocation of p65, and NF-κB transcriptional activity. These findings suggest that TC may have therapeutic potential for the treatment of AD.